The Committees

Organizing Committee

Harley Eisman, MD, Chair

Co-Founder, Hereditary Breast and Ovarian Cancer Foundation, Montréal, QC, Canada

William Foulkes, MBBS, PhD, Scientific Programme Director

Director, Program in Cancer Genetics, McGill University, Montréal, QC, Canada

Laura Hayes, Public Conference Programme Director

McGill University, Montréal, QC, Canada

Scientific Committee

William Foulkes, MBBS, PhD

Director, Program in Cancer Genetics, McGill University, Montréal, QC, Canada (Chair)

Lawrence Brody, PhD

National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA

Wendy McKinnon, MS, CGC

University of Vermont Cancer Center, Burlington, VT, USA

Jorge Reis-Filho, MD, PhD

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Mark Robson, MD

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Marc Tischkowitz, MBBS, PhD

University of Cambridge, Cambridge, UK



Abstract Review Committee:

Patricia N. Tonin, PhD

The Research Institute of the MUHC, Montréal, QC, Canada (Chair)

Antonis Antoniou, PhD

Cancer Risk Prediction, University of Cambridge, Cambridge, UK

Ian Campbell, PhD

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Bartha Maria Knoppers, PhD

Centre of Genomics and Policy, McGill University, Montréal, QC, Canada

Lisa Madlensky, PhD, CGC

Moores UCSD Cancer Center, University of California San Diego, La Jolla, CA, USA

Alvaro Monteiro, PhD

Moffitt Cancer Center, Tampa, FL, USA

Jorge Reis-Filho, MD, PhD

Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Marc Tischkowitz, MD, PhD

University of Cambridge, Cambridge, UK

Clare Turnbull, MBBS, PhD

Genomics England and Queen Mary University of London, London, UK

Britta Weigelt, PhD

Memorial Sloan-Kettering Cancer Center, New York, NY, USA



PHOTO: Mary Queen of the World Cathedral / Skyline of downtown Montréal. © Tourisme Montréal